Number of Shares
228,317.00
Current Holdings Value*
$433,800.00
% of Portfolio
0.51%
Total Estimate Gain
$-4,566.34
% of Total Estimate Gain
-0.75%

Propel Bio Management, LLC's Compass Therapeutics Inc Holding Summary

As of 2025-03-31, Propel Bio Management, LLC held 228,317.00 shares of Compass Therapeutics Inc(CMPX), totaling $433,800.00. This investment constitutes 0.51% of their stock portfolio, and Propel Bio Management, LLC now holds 0.17% of the outstanding Compass Therapeutics Inc(CMPX) stock.

The initial trade took place in 2025Q1. And since then Propel Bio Management, LLC has made 1 purchases of CMPX, at an average price of $2.66, for a total of 228,317.00 shares. Based on historical transaction data and CMPX's current price of $2.64, Propel Bio Management, LLC's estimated gain on his CMPX holdings is $-4,566.34, reflecting a -0.75% gain to date.

Propel Bio Management, LLC CMPX ($2.64) Holding Chart

Propel Bio Management, LLC CMPX ($2.64) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1